Hikma Pharmaceuticals PLC (LSE:HIK)
£ 19.14 -0.01 (-0.05%) Market Cap: 4.25 Bil Enterprise Value: 4.98 Bil PE Ratio: 28.48 PB Ratio: 2.43 GF Score: 91/100

Half Year 2024 Hikma Pharmaceuticals PLC Earnings Presentation (Pre-Recorded) Transcript

Aug 08, 2024 / 06:00AM GMT
Release Date Price: £19.92 (+8.26%)
Riad Mishlawi
Hikma Pharmaceuticals PLC - Chief Executive Officer, Executive Director

Presentation (Pre-Recorded)
Aug 08, 2024 / 06:00AM GMT

=====================
Corporate Participants
=====================
* Riad Mishlawi
Hikma Pharmaceuticals PLC - Chief Executive Officer, Executive Director
* Khalid Nabilsi
Hikma Pharmaceuticals PLC - Chief Financial Officer

=====================
-

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot